Form 4: Clorox Director Matthew Shattock Boosts Stake Through Deferred Stock Units

Clorox Director Matthew J. Shattock increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and receipt of director's fees in lieu of cash.

Summary

• Matthew J. Shattock, a Director of The Clorox Company (CLX), increased his beneficial ownership of Deferred Stock Units (DSUs).
• On May 9, 2025, 144.0464 DSUs were acquired through dividend reinvestment, pursuant to the Independent Directors' Deferred Compensation Plan.
• On June 30, 2025, an additional 426.8343 DSUs were received in lieu of quarterly director's fees.
• Following these transactions, Mr. Shattock's total beneficial ownership of DSUs is 16,482.1002.
• These Deferred Stock Units will be settled 100% in Clorox common stock upon Mr. Shattock's retirement or other termination of service as a Director.

Sentiment

Score: 7

Explanation: The filing indicates a director's increased beneficial ownership through routine compensation and dividend reinvestment, which generally signals alignment with long-term shareholder value.

Positives

• Director Matthew J. Shattock increased his beneficial ownership of Clorox Deferred Stock Units, signaling continued alignment with shareholder interests.
• The acquisition of Deferred Stock Units through dividend reinvestment and in lieu of cash fees demonstrates a commitment to long-term investment in the company.

Future Outlook

Deferred Stock Units held by the director will be settled 100% in Clorox common stock upon the reporting person's retirement or other termination of service as a Director.

Industry Context

This filing is a routine disclosure of an insider transaction, reflecting a director's compensation structure and personal investment in the company, rather than broader industry trends.

Related Party Transactions

• Acquisition of Deferred Stock Units by Director Matthew J. Shattock through dividend reinvestment and in lieu of quarterly director's fees, as part of the Independent Directors' Deferred Compensation Plan.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director aligns management's interests more closely with those of shareholders, potentially fostering confidence in the company's long-term prospects.

Next Steps

• Deferred Stock Units will be settled in Clorox common stock upon the reporting person's retirement or other termination of service as a Director.

Key Dates

Recommendation

Keywords

Clorox, CLX, Form 4, SEC filing, insider transaction, director compensation, deferred stock units, beneficial ownership